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Background and Objectives: Hand eczema is a chronic disease with negative impact on quality of life
(QoL). In this study, QoL in hand eczema patients is assessed and related to age, sex, severity, and
diagnostic subgroups.
Methods: A total of 416 patients with hand eczema from 10 European patch test clinics participated
in the study. Data on QoL were obtained from a self-administered questionnaire using the Derma-
tology Life Quality Index (DLQI). Severity was assessed by a scoring system (Hand Eczema Severity
Index, HECSI) as well as frequency of eruptions and sick leave due to hand eczema.
Results: No significant difference was found between males and females with respect to QoL [DLQI
median values and 25/75 percentiles for males and females being 7.0 (3–14) and 8.0 (3–13), respec-
tively], although males were more severely affected than females (P < 0.025). A significant positive
correlation was found for hand eczema severity and age (P < 0.001), while no significant correlation
was found for QoL and age. QoL was found increasingly reduced when sick leave was getting higher
(P < 0.001). A statistically significant correlation between QoL (as measured by DLQI) and hand
eczema severity as measured by HECSI was found (P < 0.001). No significant difference in QoL was
found between diagnostic subgroups.
Conclusions: QoL was found markedly negatively affected in hand eczema patients and was signifi-
cantly correlated to disease severity. No significant difference in QoL was found between males and
females, in spite of significantly more severe eczema in males, indicating that QoL in female patients
is more easily affected.
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Hand eczema is one of the most frequently seen
diseases in dermatological practice. For one third
of patients with hand eczema, the disease starts
before 20 years of age (1), and it is often occupa-
tionally related (2). Due to its chronic course with
*European Environmental and Contact Dermatitis
Research Group (EECDRG) (http://orgs.dermis.net/
content/e05eecdrg/index_ger.html).
mean disease duration of more than 10 years,
hand eczema is an expensive disease for society
and a burden for the individual (3, 4). Parameters
such as severity, sick leave, and job loss may be
used for assessment of the burden of the disease
(5), but for the patient, the quality of life (QoL) is
essential. Theoretically, QoL may be assessed by
generic (global), dermatology-specific or disease-
specific questionnaires (6). However, for hand
eczema, no disease-specific questionnaire has yet
been developed, but both generic and dermatol-
ogy-specific questionnaires have proved valuable
(7, 8). Recent studies provide data showing equal
impairment of QoL in patients with severe hand
eczema and patients with atopic dermatitis and
psoriasis (8). This study assesses QoL in hand
eczema patients referred to dermatological clinics
in different centres in Europe, relates QoL to dis-
ease severity and diagnostic subgroups of hand
eczema, and identifies which factors influence
QoL.
Materials and Methods
The study is a cross-sectional, multicentre study
and was performed within the European Environ-
mental and Contact Dermatitis Research Group
(EECDRG) (http://orgs.dermis.net/content/
e05eecdrg/index_ger.html) in the period Septem-
ber 2005–August 2006. Patients with hand eczema
referred to one of the 10 participating patch test
clinics in Europe were invited to participate.
Patients were included consecutively. Because par-
ticipation in the study for the patients only meant
to complete the QoL questionnaire, virtually all
invited to participate in the study actually parti-
cipated. Medical history including information
about atopy, psoriasis, domestic and occupational
exposures, frequency of eruptions, and sick leave
was registered. All participants were patch tested
with the European baseline series with 2 days
occlusion and at least two readings, and under-
went additional testing when needed. Finn
Chambers1 (Epitest, Tuusula, Finland) were used
in seven centres; in one centre, True test panels 1
and 2 were used additionally to Finn Chambers,
and three centres used Van der Bend chamber
(Brielle, the Netherlands) or IQ chamber (Chemo-
technique, Vellinge, Sweden).
Data on QoL were obtained from a self-
administered questionnaire using the Dermatol-
ogy Life Quality Index (DLQI) (9). This is a
dermatology-specific questionnaire, which previ-
ously has proved useful for assessment of QoL
in hand eczema patients (8, 10). The DLQI is a
10-item questionnaire, which covers six aspects
of daily life experienced during the past week:
(i) symptoms and feelings, (ii) daily activities, (iii)
leisure items, (iv) work and school, (v) personal
relationship items, and (vi) treatment. The DLQI
score is calculated by summing the score of each
question, with a maximum score of 30 and a min-
imum score of 0. The higher the score, the greater
the impairment of life.
The clinical examination included evaluation of
severity by use of a scoring system (Hand Eczema
Severity Index, HECSI) (11). HECSI includes
scoring of morphological symptoms including
erythema, infiltration, vesicles, fissures, scaling,
and oedema as well as a scoring of the affected
area on the hands (fingertips, fingers, palms, back
of hand, and wrist).
The diagnostic options, based on clinical prac-
tice and decided after discussion in the EECDRG
group, were allergic contact dermatitis (ACD),
irritant contact dermatitis (ICD), atopic hand
eczema (AHE), vesicular hand eczema, and hyper-
keratotic hand eczema (manuscript in prepara-
tion). The diagnoses ACD and ICD were used
only when relevant allergic or irritant exposures
were assessed. More than one diagnosis could be
provided for each patient.
Statistics
For comparison between groups, the chi-squared
test was used, and when more than two groups
were included, the Kruskal–Wallis test was used.
The Spearman correlation was used for correla-
tion studies.
Results
A total of 416 patients from the 10 clinics were
included, each clinic contributing 27–64 patients
(4 clinics contributed 50 patients, 1 clinic 64
patients, and 5 clinics contributed less than 50
patients). Median age was 39 years (range 18–78
years), and participants were 252 females and 164
males. 23.5% had a personal history of atopic
dermatitis (AD), 3.8% reported psoriasis, and
63.0% had contact sensitization to one or more
Table 1. Median values (25/75 percentiles) for DLQI and
HECSI given for males and females (n ¼ 416)a
Total Males Females P value
DLQI 8.0 (4.0–13.0) 7.0 (3.0–14.0) 8.0 (4.0–13.0) 0.406
HECSI 17.0 (8.0–35.0) 20.5 (10.0–51.0) 14.5 (6.0–30.0) <0.025
DLQI, Dermatology Life Quality Index; HECSI, Hand Eczema
Severity Index.
aHigher score indicates more negative impairment on quality of
life. Statistically significant higher HECSI score was found in
males compared with females, while no significant difference was
found for DLQI values.
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of the tested allergens. About 51.7% of all cases
were reported as having occupational hand
eczema.
DLQI and HECSI scores for assessment of
QoL and hand eczema severity, respectively, are
given in Table 1. Statistically significantly higher
HECSI scores were found in males compared with
females, while no significant difference was found
for DLQI values (Table 1). The distribution of
DLQI and HECSI scores in different age groups
is given in Fig. 1. A significant positive correlation
was found for HECSI and age (P < 0.001), while
no significant correlation was found for DLQI
and age (P ¼ 0.11). Data for DLQI in relation
to sick leave and frequency of eruptions are given
in Tables 2 and 3. Increasing DLQI values, indi-
cating lower QoL, were found with increasing sick
leave (P< 0.001), and a trend was found for lower
QoL with increasing number/duration of erup-
tions (P ¼ 0.051).
A statistically significant positive correlation be-
tween DLQI and HECSI was found (P < 0.001),
as shown in Fig. 2. For 316 patients, a precise
diagnosis according to the given subgroups was
made (manuscript in preparation), and DLQI
values for these are given in Fig. 3. No statistically
significant differences were found between the
groups (P ¼ 0.11), but there was a trend that
QoL was most impaired in patients with ACD
Fig. 1. DLQI (a) and HECSI (b) for the different age groups.
Median values and 25/75 percentiles are given (boxes) as well
as mean values (þ), maximum and minimum observations.
No significant correlation was found for DLQI and age
(P ¼ 0.11), while a significant positive correlation was found
for HECSI and age (P < 0.001). DLQI, Dermatology Life
Quality Index; HECSI, Hand Eczema Severity Index.
Table 2. Median values and 25/75 percentiles for DLQI in rela-
tion to sick leave (n ¼ 416)a
Sick leave DLQI
No sick leave (n ¼ 299) 6.0 (3.0–12.0)
<1 week (n ¼ 13) 5.0 (2.0–14.0)
1–5 weeks (n ¼ 53) 10.0 (5.0–17.0)
>5 weeks (n ¼ 51) 13.5 (8.0–18.0)
DLQI, Dermatology Life Quality Index.
aThere was a statistically significant difference in DLQI between
the groups with respect to sick leave (P < 0.001).
Table 3. Median values and 25/75 percentiles for DLQI in rela-
tion to number of eruptions (n ¼ 414)a
Eruptions* DLQI
Less than four eruptions/year (n ¼ 42) 6.0 (1.0–11.0)
More than eruptions/year (n ¼ 102) 8.0 (3.0–12.0)
Persistent dermatitis (n ¼ 270) 8.0 (4.0–14.0)
DLQI, Dermatology Life Quality Index.
aThere was a statistical trend for differences between the groups
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Fig. 2. A statistically significant positive correlation between
Dermatology Life Quality Index and Hand Eczema Severity
Index was found (n ¼ 416, P < 0.001).
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and vesicular eczema and less affected in patients
with ICD.
Discussion
In the present material of patients with hand
eczema, referred to specialized European clinics,
a median DLQI score of 8.0 was found, under-
lining that hand eczema is a diagnosis with signi-
ficantly negative impact on QoL. The positive
correlation between DLQI and HECSI shows
a close relationship between QoL and disease
severity and supports measurement of DLQI as
a clinically relevant parameter. For the first time,
QoL in relation to diagnostic subgroups of hand
eczema is reported.
The study population was a typical cohort of
hand eczema patients with respect to age and sex
distribution. Contact sensitization was found in
63% of the population, which is higher than that
reported in studies of hand eczema patients
recruited from the background population (12),
but in agreement with findings in patents with
occupational hand eczema (13), which was diag-
nosed in half of the patients. The high sick leave
frequency and the fact that more than 60%
reported persistent dermatitis indicate that this
population was severely affected. This was to be
expected because the patients were referred to spe-
cialized dermatological clinics.
QoL was assessed by the DLQI. As opposed to
generic questionnaires (e.g. the Short Form-36,
SF-36), DLQI is a dermatology-specific question-
naire, which has proved useful for assessment of
QoL among hand eczema patients. Comparing
the efficacy of the DLQI and the generic SF-36
questionnaire for assessment of QoL in hand
eczema favoured the SF-36, and a recent study
found this to be a more accurate instrument in
measuring mental health DLQI (7). However,
the DLQI is a simpler and shorter questionnaire
expected to give better compliance and was chosen
for that reason. Ideally, a QoL questionnaire for
hand eczema patients should include questions on
work-related impairment of both physical func-
tioning and interaction with colleagues (14), but
such instruments are not at the moment available
for this disease.
The DLQI median score of 8.0 was in agree-
ment with previous findings in patients with severe
occupational hand eczema, where DLQI was
reported to be 7.8. (8), and comparable to DLQI
values found in moderate psoriasis and atopic
dermatitis.
Although females had less severe hand eczema
than males, QoL was equally affected. In a previ-
ous study (7) using the SF-36 questionnaire,
health-related QoL was reported more impaired
for females with hand eczema than for males in
the mental health dimension, whereas no sex-
related differences were detected with the DLQI,
in agreement with our present findings. Another
study in patients with ACD, using the Skindex-16
questionnaire for assessment of QoL, found no
statistically significant sex-related differences in
QoL scores, although also in this study females
reported a higher degree of emotional distress
(15, 16). The studies all indicate that QoL in
female patients is more easily affected than in male
patients. This may be related to the tradition that
females take care of most domestic work and that
this part of their life is being affected, or it may be
related to the negative cosmetic influence of the
disease, which also traditionally may be expected
to cause more distress in females, and was recently
reported to do so in female AD patients (17).
A positive correlation between HECSI and age
illustrates that the hand eczemamay becomemore
severe in older age groups, while the QoL was not
significantly affected with increasing age. In
a recent study, more younger subjects with ACD
reported a significantly injured QoL compared
with older age groups (16), while no association
between QoL and age was found in a population
of patients with occupational hand eczema (8).
Increased severity of the eczema but no significant
worsening of QoL indicates that hand eczemamay
become more tolerated with increasing age.
The correlation between DLQI and HECSI,
assessing the QoL and hand eczema severity,
respectively, was expected and supports the rele-
vance of both scoring systems. A correlation
between severity and QoL in patients with occupa-
tional hand eczema has previously been reported
(8, 10), but the positive correlation betweenHECSI
and DLQI is reported in this study for the first
Fig. 3. DLQI score for diagnostic subgroups (n ¼ 316). No
significant difference was found between the groups (P ¼
0.111). Median values and 25/75 percentiles are given (boxes)
as well as mean values (þ), maximum and minimum obser-
vations. ACD, allergic contact dermatitis; AHE, atopic hand
eczema; Hyper., hyperkeratotic hand eczema; ICD, irritant
contact dermatitis; Vesicul., vesicular hand eczema.
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time. Frequent eczema eruptions and long dura-
tion of sick leave contributed negatively to QoL,
as would be expected. No significant differences in
DLQI score between diagnostic subgroups of hand
eczema was found, and this is in agreement with
a previous study on occupational hand eczema
where no difference in DLQI was reported between
hand eczema patients diagnosed as allergic or irri-
tant dermatitis or contact urticaria (8).
Conclusions
Our data confirm that patients with hand eczema,
referred to specialized clinics for examination and
treatment, have a significantly negatively affected
QoL. Males and females had equally impaired
QoL, although males had significantly more
severe eczema. A significantly positive correlation
between DLQI and disease severity was found,
supporting the use of DLQI as a relevant clinical
parameter.
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